Clinical trial
Efficacy and Safety of Sirolimus in LAM
NCT00414648 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00414648 |
|---|---|
| Title | Efficacy and Safety of Sirolimus in LAM |
| Official title | Multicenter International Lymphangioleiomyomatosis Efficacy and Safety of Sirolimus Trial |
| Acronym | MILES |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | Office of Rare Diseases (ORD) NIH FDA Office of Orphan Products Development U.S. Fed National Center for Research Resources (NCRR) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphangioleiomyomatosis |
| Intervention type | Drug |
| Interventions | Sirolimus, Placebo |
| Enrollment | 89 |
| Start date | Dec 1, 2006 |
| Primary completion | Sep 1, 2010 |
| Completion | Feb 1, 2011 |
| First posted | Dec 21, 2006 |
| Last update posted | Nov 2, 2023 |
| Countries | Canada, Japan, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: